Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results-Reference-Cited by-同舟云学术

Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results

Published:2017-01-12 Issue:4 Volume:35 Page:554-560
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

De Sanctis Vitaliana¹,Alfò Marco²,Di Rocco Alice³,Ansuinelli Michela³,Russo Eleonora³,Osti Mattia F.¹,Valeriani Maurizio¹,Minniti Giuseppe¹⁴,Grapulin Lavinia⁵,Musio Daniela⁵,Bracci Stefano¹,Spagnoli Alessandra⁶,Moleti Maria Luisa³,Tombolini Vincenzo⁵,Martelli Maurizio³

Affiliation:

1. Department of Medicine and Surgery and Translational Medicine, Unit of Radiotherapy, S Andrea Hospital; “Sapienza” University of Rome; Rome Italy

2. Department of Statistical Sciences; “Sapienza” University of Rome; Rome Italy

3. Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I; “Sapienza” University of Rome; Rome Italy

4. IRCCS Neuromed; Pozzilli (IS); Italy

5. Department of Radiological, Oncological and Anatomo-pathological Sciences, Unit of Radiotherapy, Policlinico Umberto I; Sapienza” University of Rome; Rome Italy

6. Department of Public Health and Infectious Diseases; “Sapienza” University of Rome; Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference45 articles.

1. Primary mediastinal lymphoma: diagnosis and treatment options;Martelli;Expert Rev Hematol,2015

2. Primary mediastinal large B-cell lymphoma;Bhatt;Cancer Treat Rev,2015

3. Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies;Zinzani;Curr Oncol Rep,2011

4. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study;Rieger;Ann Oncol,2011

5. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care;Vassilakopoulos;Oncologist,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy;Russian journal of hematology and transfusiology;2022-10-22

2. Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions;Frontiers in Oncology;2021-03-22

3. Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study;In Vivo;2020

4. A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed;Cancers;2019-11-13

5. Long-Term Outcomes in Survivors of Childhood and Adolescent Non-Hodgkin Lymphoma;Non-Hodgkin's Lymphoma in Childhood and Adolescence;2019